đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
This study is designed to 1) describe the safety, tolerability, and immunog...
Status
Completed
Location
Bliss Healthcare Services ( Site 0010)
Start Date
2018-07-06
Trial ID
NCT03480802
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
Primary Objective: To demonstrate the non-inferiority of the SHAN6⢠vaccin...
Status
Completed
Location
Investigational Site Number 7640003
Start Date
2020-06-28
Trial ID
NCT04429295
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Morinaga Maternity Clinic ( Site 3345)
Start Date
2020-07-01
Trial ID
NCT04384107
The purpose of this study is to assess safety profile of Prevenar 13⢠when ...
Status
Completed
Location
Chungnam National University Hospital (CNUH)
Start Date
2013-12
Trial ID
NCT01834222
Treatments Being Tested
The purpose of this study is 1) to evaluate the safety and tolerability of ...
Status
Completed
Location
Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
Start Date
2019-06-25
Trial ID
NCT03885934
Treatments Being Tested